Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. NTNX
9. HPQ
10. A

Go back to Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe
Amgen Inc (NASDAQ: AMGN) Delayed: 437.42 -2.92 (0.66%)
Previous Close $440.34    52 Week High $176.85 
Open $433.08    52 Week Low $133.64 
Day High $442.13    P/E 65.88 
Day Low $431.01    EPS $6.64 
Volume 1,060,247